ロード中...

NK cells and CD38: Implication for (Immuno)Therapy in Plasma Cell Dyscrasias

Immunotherapy represents a promising new avenue for the treatment of multiple myeloma (MM) patients, particularly with the availability of Monoclonal Antibodies (mAbs) as anti-CD38 Daratumumab and Isatuximab and anti-SLAM-F7 Elotuzumab. Although a clear NK activation has been demonstrated for Elotuz...

詳細記述

保存先:
書誌詳細
出版年:Cells
主要な著者: Zambello, Renato, Barilà, Gregorio, Manni, Sabrina, Piazza, Francesco, Semenzato, Gianpietro
フォーマット: Artigo
言語:Inglês
出版事項: MDPI 2020
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7140687/
https://ncbi.nlm.nih.gov/pubmed/32245149
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9030768
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!